Michael Narachi's Net Worth

$3.2 Million

Estimate Recalculated Jul 3, 2024 01:10PM EST

Who is Michael Narachi?

Michael Narachi has an estimated net worth of $3.2 Million. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., Celladon Corp, Ultragenyx Pharmaceutical Inc., and AMAG PHARMACEUTICALS INC..

SEC CIK

Michael Narachi's CIK is 0001380022

Past Insider Trading and Trends

2012 was Michael Narachi's most active year for acquiring shares with 11 total transactions. Michael Narachi's most active month to acquire stocks was the month of May. 2012 was Michael Narachi's most active year for disposing of shares, totalling 12 transactions. Michael Narachi's most active month to dispose stocks was the month of June. 2011 saw Michael Narachi paying a total of $2,260,800.00 for 4,731,150 shares, this is the most they've acquired in one year. In 2012 Michael Narachi cashed out on 1,050,000 shares for a total of $3,479,884.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Orexigen Therapeutics, Inc. No price found

CEO & President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 13
Form 4
+8.10%
626
$1.55
$970.30
8.36K
May 31
Form 4
—
0
—
—
0
Feb 3
Form 4
+14.56%
802
$1.67
$1,339.34
6.31K
Nov 30
Form 4
—
0
—
—
0
Jul 12
Form 4
+14.51%
8.78K
$0.34
$2,984.18
69.28K
May 31
Form 4
+4.28%
2.48K
$2.65
$6,581.40
60.51K
May 29 - Feb 2
Form 4
—
0
—
—
0
Feb 3
Form 4
+622.98%
50K
$4.78
$239,100.00
58.03K
Sep 15
Form 4
∞
3.98K
$5.34
$21,253.20
3.98K
Nov 29 - Feb 7
Form 4
—
0
—
—
0
Feb 15
Form 4
—
0
$4.67
-$898,969.52
0
Scheduled
Jul 17
Form 4
—
0
$4.18
-$755,884.00
0
Scheduled
Jul 12 - Jul 13
Form 4
—
0
$3.78
-$952,500.00
0
Scheduled
Jun 28 - Jun 29
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
—
—
0
Jul 22 - Jul 25
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
Sep 20
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
Apr 2
Form 3
—
0
—
—
0
No matching records found

Celladon Corp (EIGR) Snapshot price: $6.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
May 20
Form 4
∞
62.5K
$8.00
$500,000.00
62.5K
Feb 4
Form 3
—
0
—
—
0
No matching records found

Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $45.89

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+24.74%
5.34K
—
—
26.95K
Jun 18
Form 4
+21.75%
3.86K
—
—
21.61K
Jun 7
Form 4
+22.85%
3.3K
—
—
17.75K
Jun 24
Form 4
+17.44%
2.15K
—
—
14.45K
Jun 24
Form 4
+26.15%
2.55K
—
—
12.3K
Jun 26
Form 4
+44.44%
3K
—
—
9.75K
Jun 11
Form 4
+80.00%
3K
—
—
6.75K
Jun 19
Form 4
+100.00%
1.88K
—
—
3.75K
Jun 22
Form 4
∞
1.88K
—
—
1.88K
Jun 9
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Feb 20
Form 3
—
0
—
—
0
No matching records found

AMAG PHARMACEUTICALS INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+18.91%
3.8K
—
—
23.9K
May 23
Form 4
∞
7.5K
$13.55
—
7.5K
May 24 - May 25
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Oct 6
Form 4
—
0
—
—
0
Dec 19
Form 4
—
0
—
—
0
Aug 5
Form 4
—
0
—
—
0
Nov 27
Form 4
—
0
—
—
0
Nov 7
Form 3
—
0
—
—
0
No matching records found